SE448377B - (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyraanilider och syraadditionssalter derav samt beta-adrenolytiskt verksamt lekemedel vars aktiva substans utgores av nemnda foreningar - Google Patents

(3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyraanilider och syraadditionssalter derav samt beta-adrenolytiskt verksamt lekemedel vars aktiva substans utgores av nemnda foreningar

Info

Publication number
SE448377B
SE448377B SE8004351A SE8004351A SE448377B SE 448377 B SE448377 B SE 448377B SE 8004351 A SE8004351 A SE 8004351A SE 8004351 A SE8004351 A SE 8004351A SE 448377 B SE448377 B SE 448377B
Authority
SE
Sweden
Prior art keywords
furan
group
denotes
carbonic
formula
Prior art date
Application number
SE8004351A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004351L (sv
Inventor
J Uhlendorf
H Betzing
H Gabbar
E Graf
I-S Doppelfeld
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of SE8004351L publication Critical patent/SE8004351L/xx
Publication of SE448377B publication Critical patent/SE448377B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SE8004351A 1979-06-12 1980-06-11 (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyraanilider och syraadditionssalter derav samt beta-adrenolytiskt verksamt lekemedel vars aktiva substans utgores av nemnda foreningar SE448377B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2923817A DE2923817C2 (de) 1979-06-12 1979-06-12 (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen

Publications (2)

Publication Number Publication Date
SE8004351L SE8004351L (sv) 1980-12-13
SE448377B true SE448377B (sv) 1987-02-16

Family

ID=6073081

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004351A SE448377B (sv) 1979-06-12 1980-06-11 (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyraanilider och syraadditionssalter derav samt beta-adrenolytiskt verksamt lekemedel vars aktiva substans utgores av nemnda foreningar

Country Status (14)

Country Link
US (1) US4269855A (de)
JP (1) JPS562977A (de)
AT (1) AT376428B (de)
AU (1) AU535945B2 (de)
BE (1) BE883766A (de)
CA (1) CA1146953A (de)
CH (1) CH643250A5 (de)
DE (1) DE2923817C2 (de)
FR (1) FR2458548A1 (de)
GB (1) GB2051796B (de)
IT (1) IT1131822B (de)
NL (1) NL8003385A (de)
SE (1) SE448377B (de)
ZA (1) ZA803466B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510573B1 (fr) * 1981-07-29 1985-07-26 Carpibem (2-substitue 4-(thienyl acetamido) phenoxy) hydroxy propylamines, leur preparation, leur utilisation en therapeutique, et nouveaux intermediaires
FR2530245A1 (fr) * 1982-07-16 1984-01-20 Carpibem Nouveaux 1-(2-carbalkoxy 4-(thienyl-alkylamido)phenoxy) 3-amino 2-propanols, leur preparation et leurs applications en therapeutique
IE56108B1 (en) * 1982-07-16 1991-04-24 Carpibem 1-(2-carbalkoxy-4-(thienylcarboxamido)phenoxy)-3-amino 2-propanols,their preparation and applications thereof in therapeutics
FR2555179B1 (fr) * 1983-11-21 1986-11-21 Carpibem Nouveaux (carbethoxy-2 furyl- ou benzofuryl-carboxamido-4 phenoxy)-1 amino-3 propanols-2 : leurs preparations et leurs applications en therapeutique
US6300368B1 (en) * 1998-06-30 2001-10-09 Mitsui Chemicals, Inc. Anilide derivatives and antiarrhythmic agents containing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1543689A (fr) * 1966-11-03 1968-10-25 Ici Ltd Procédé de fabrication de nouvelles alcanolamines et de leurs dérivés
US3959481A (en) * 1969-02-13 1976-05-25 Uniroyal Method of protecting plants from fungal diseases using furan-3-carboxamide derivatives
JPS5749552B2 (de) * 1972-06-07 1982-10-22
GB1531718A (en) * 1974-11-20 1978-11-08 Pharmacia As Phenylethanolamines
DE2800504A1 (de) * 1978-01-05 1979-07-12 Consortium Elektrochem Ind Verfahren zur herstellung von furancarbonsaeureanilid

Also Published As

Publication number Publication date
NL8003385A (nl) 1980-12-16
SE8004351L (sv) 1980-12-13
ZA803466B (en) 1981-06-24
FR2458548B1 (de) 1983-08-05
AT376428B (de) 1984-11-26
JPS562977A (en) 1981-01-13
CA1146953A (en) 1983-05-24
FR2458548A1 (fr) 1981-01-02
IT8022724A0 (it) 1980-06-11
DE2923817B1 (de) 1980-08-14
GB2051796B (en) 1983-04-27
BE883766A (fr) 1980-10-01
DE2923817C2 (de) 1981-07-09
IT1131822B (it) 1986-06-25
GB2051796A (en) 1981-01-21
AU535945B2 (en) 1984-04-12
AU5921280A (en) 1980-12-18
ATA307580A (de) 1984-04-15
US4269855A (en) 1981-05-26
CH643250A5 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
US3929793A (en) Certain piperazine-containing indole compounds
US3723524A (en) Polar-substituted propanolamines as anti-angina and anti-hypertensive agents
US3793365A (en) Amino acid derivatives
US4081447A (en) 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US3852291A (en) Heterocyclic derivatives of phenoxypropanolamines
SE436874B (sv) N-substituerade moranolinderivat
CS197304B2 (en) Method of producing novel 1-aryloxy- 2-hydroxy-3-alkylenamino propanes
US3974156A (en) 2-(Substituted anilino) methylmorpholine compounds
SE448377B (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyraanilider och syraadditionssalter derav samt beta-adrenolytiskt verksamt lekemedel vars aktiva substans utgores av nemnda foreningar
US3931212A (en) Method for treating cardiovascular circulatory insufficiencies and hypotonia with 2-hydroxy-phenyl-1-oxa-4-azaspiroalkane derivatives
EP0116360A1 (de) 1-Phenyl-2-aminocarbonylindol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4977153A (en) 3-aminopropyloxyphenyl derivatives, pharmaceutical compositions containing them and method for the therapy of diseases
US4056626A (en) Pharmaceutical composition containing benzofuran derivative
US3177211A (en) 10-[(aminocarbamyl-1-piperidyl)-loweralkyl]-phenothiazines
US4209527A (en) Benzimidazolone derivatives
HUT61538A (en) Process for producing new 2-amino-5-cyano-1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US4110472A (en) Derivatives of 1-(disubstituted phenoxy)-3-amino-2-hydroxypropanes
DE3423429A1 (de) Substituierte phenoxyalkylaminopropanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US3845123A (en) Phenoxypropanolamine therapeutic agents
AU594840B2 (en) 1-aryloxy-3-amino-2-propanols
CA1128940A (en) Phenothiazine derivatives and a process for the preparation thereof
US3850947A (en) 3-thiazol-4'-oxy-aminopropanol cardiovascular agents
DD258812A1 (de) Verfahren zur herstellung neuer ixoxazolderivate
JPH09169747A (ja) 新規置換フェニルチアゾリジン−２，４−ジオン誘導体及びその製造法

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004351-6

Effective date: 19880318

Format of ref document f/p: F